TilrayTilray's stock surge of 27% on Wednesday is a big win for retail traders, following the release of its first earnings report since merging into Aphria.Wall Street Bets posted that cannabis company EBITDA grew 285% year-over-year.Tilray is still far from its 2018 highs, but many retail traders are optimistic that the stock will rebound "to the moon."Subscribe to our daily newsletter 10 Things Before The Opening Bell.Tilray's stock price of 27% on Wednesday was cheered by retail investors after it posted its first quarter earnings following the merger with Aphria.Toronto-based company, $16.18 on Wednesday was the highest intraday point in more than two weeks. However, it is still far below its 2018 post-IPO record, $300."$TLRY This is going back up to $150. Buy and Hold! Stocktwits users shared their thoughts. Another user commented that the stock could be "life-changing". Stocktwits' Wednesday morning trend showed Tilray as the #1 stock.For the fourth quarter of fiscal 2016, the cannabis company reported net income of $33.6million, which was a decrease of $84.3 million over the previous year. EBITDA nearly quadrupled, reaching $12.3 million."Still down, but we're moving forward. To the moon boys! Reddit user comments on WallStreetBet post that highlights the 285% increase in yoy adjusted EBITDA.Tilray's stock fell 5% after it completed its merger in May with Aphria, but the company claimed it has already seen cost savings of millions of dollars as a result.Tilray CEO Irwin D. Simon stated that "in a very short time since our business merger was completed, we transformed and strengthened Tilray and delivered solid results amid ongoing COVID-19 restrictions and lockdowns, and achieved $35,000,000 in synergies so far - well on the way to delivering $80M in cost savings over 16 months."Fintel reports that these 5 stocks could offer retail investors the best chance for a quick squeeze this week.
